Drug Trial Radar · NCT06431373
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Last checked: Nov 19, 2026Latest source record: Jan 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
371
Actual
Start
Sep 11, 2024
Primary completion
Sep 11, 2026
Study completion Feb 1, 2028
Sponsor
- Lead sponsor
- Priovant Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Conditions
- Uveitis, Posterior
- Uveitis, Intermediate
- Uveitis
Interventions
Brepocitinib PO QDDrug
Brepocitinib PO QD
Placebo PO QDDrug
Placebo PO QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to treatment failure on or after Period 1 Week 6 up to Period 1 Week 48Time frame: 48 weeks
Locations
107 sites in 13 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Phoenix, Arizona
Clinical Trial Site
Phoenix, Arizona
Clinical Trial Site
Bakersfield, California
Clinical Trial Site
Beverly Hills, California
Clinical Trial Site
Fullerton, California
Clinical Trial Site
Irvine, California
Clinical Trial Site
La Jolla, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
Modesto, California
Clinical Trial Site
Sacramento, California
Clinical Trial Site
Aurora, Colorado
Clinical Trial Site
Denver, Colorado
Clinical Trial Site
Fort Lauderdale, Florida
Clinical Trial Site
St. Petersburg, Florida
Clinical Trial Site
Chicago, Illinois
Clinical Trial Site
Oak Park, Illinois
Clinical Trial Site
Carmel, Indiana
Clinical Trial Site
Prairie Village, Kansas
Clinical Trial Site
Baltimore, Maryland
Clinical Trial Site
Boston, Massachusetts
Clinical Trial Site
Waltham, Massachusetts
Clinical Trial Site
Ann Arbor, Michigan
Clinical Trial Site
Detroit, Michigan
Clinical Trial Site
Detroit, Michigan
Clinical Trial Site
Minneapolis, Minnesota
Clinical Trial Site
Rochester, Minnesota
Clinical Trial Site
St Louis, Missouri
Clinical Trial Site
Omaha, Nebraska
Clinical Trial Site
Palisades Park, New Jersey
NYU Langone Health
New York, New York
Clinical Trial Site
Rochester, New York
Clinical Trial Site
Durham, North Carolina
Clinical Trial Site
Winston-Salem, North Carolina
Clinical Trial Site
Cleveland, Ohio
Clinical Trial Site
Cleveland, Ohio
Clinical Trial Site
Columbus, Ohio
Clinical Trial Site
Portland, Oregon
Clinical Trial Site
Portland, Oregon
Clinical Trial Site
Erie, Pennsylvania
Showing 40 of 107 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.